Stem cells derived from bone marrow may serve as a novel therapeutic option to treat a disease called epidermolysis bullosa, a disorder characterized by extraordinarily fragile skin, according to a study in Blood.
Stem cells derived from bone marrow may serve as a novel therapeutic option to treat a disease called epidermolysis bullosa, a disorder characterized by extraordinarily fragile skin, according to a study in Blood.